Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin to prevent postherpetic neuralgia in acute herpes zoster
2013-000521-31Phase 3Completed
- Sponsor
- Gerencia de Atención Primaria de Mallorca
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postherpetic neuralgia (PHN) and herpes zoster (HZ) comparing Gabapentin + usual treatment with Placebo + usual treatment (2 arms). Primary endpoint: Absence of postherpetic neuralgia at 12 weeks. Started Oct 2013; status: completed.
02
Drugs
gabapentin
03
Conditions
postherpetic neuralgia (PHN)herpes zoster (HZ)
Beyond the preview
Go deeper on 2013-000521-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000521-31.